GS-441524 is a nucleoside-based antiviral compound frequently referenced in veterinary FIP management programs. As oral antiviral products become more widely adopted, tablet formulations provide a practical option for cats that require consistent daily administration over an extended treatment period.
This product delivers 60mg of GS-441524 per tablet, offering a higher-strength oral formulation suitable for weight-based treatment protocols. The concentrated dosage may help reduce tablet quantity per administration, making daily use more convenient for both caregivers and veterinary professionals.
The tablets are manufactured under controlled production procedures and packaged to support product stability during storage and transportation.
| Specification | Description |
|---|---|
| Product Name | GS-441524 Tablets |
| Active Ingredient | GS-441524 |
| Strength | 60mg |
| Product Form | Oral Tablet |
| Intended Use | Feline Care and FIP Management |
| Shelf Life | 12 Months |
| Storage Temperature | Room Temperature |
| Manufacturing Country | China |
Production batches are identified with lot numbers and expiration dates for inventory tracking and quality assurance.
Feline infectious peritonitis is a complex viral disease that develops when feline coronavirus undergoes mutation within the host. Once systemic infection occurs, the disease may involve multiple organs and tissues throughout the body.
Veterinary professionals commonly recognize several clinical presentations:
Characterized by fluid accumulation within the abdominal or thoracic cavity.
Typically associated with inflammatory lesions affecting organs such as the liver, kidneys, or lymphatic system.
May cause inflammation affecting eye structures and visual function.
Can affect the central nervous system and lead to coordination or mobility issues.
Because disease progression varies between patients, treatment plans are generally tailored to individual clinical conditions.
Each tablet contains 60mg of GS-441524, providing a higher-strength option for cats requiring elevated daily antiviral intake.
The tablet form allows convenient administration and may be preferred in situations where injectable treatment is less practical.
Manufacturing processes are designed to support consistency, stability, and uniform active ingredient distribution.
The higher tablet strength can be incorporated into various dosing strategies based on body weight and veterinary recommendations.
Room-temperature storage simplifies transportation, inventory management, and day-to-day use.
GS-441524 60mg tablets are commonly utilized in:
The oral format may support easier long-term administration for cats undergoing extended antiviral management.
To help maintain product quality:
When stored according to recommended conditions, the product remains stable for up to one year from the manufacturing date.
The tablets are packaged for veterinary distribution and feline healthcare applications. Secure packaging helps maintain product integrity throughout transportation and storage.
Suitable for supply to:
Dosage determination, treatment duration, and administration schedules should be established according to veterinary assessment and the specific needs of the animal.
